994pdclinical Activity of the Oral Selective Inhibitor of Nuclear Export (sine) Selinexor (kpt-330) in Patients with Head & Neck Squamos Cell Carcinoma (hn-scc).

Cite this paper

@article{Mahipal2014994pdclinicalAO, title={994pdclinical Activity of the Oral Selective Inhibitor of Nuclear Export (sine) Selinexor (kpt-330) in Patients with Head & Neck Squamos Cell Carcinoma (hn-scc).}, author={Amit Mahipal and Nashat Y Gabrail and Ammar W. Sukari and Hemchandra Mahaseth and Morten Mau-Sorensen and Sharon Shacham and J-R Saint-Martin and Sharon Friedlander and Yosef Landesman and Jennifer R Ellis and Eran Shacham and Jason McCartney and Ted Marshall and Dascena Vincent and Tami Rashal and Marion Ewing Kauffman and Mansoor Mirza and Albiruni Ryan Abdul Razak}, journal={Annals of oncology : official journal of the European Society for Medical Oncology}, year={2014}, volume={25 suppl_4}, pages={iv343} }